Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Altman

Showing results (741-750 of 965) with videos related to

Pageof 97
Sort By:
BMJ (Clinical Research Ed.)|February 17, 2010
The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviewsJamie J Kirkham, Kerry M Dwan, Douglas G Altman, et al.
Health Technology Assessment (Winchester, England)|September 23, 2003
Evaluating non-randomised intervention studiesJ J Deeks, J Dinnes, R D'Amico, et al.
Systematic Reviews|April 16, 2014
Evaluation of the Cochrane Collaboration's tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementationJelena Savović, Laura Weeks, Jonathan A C Sterne, et al.
Journal of Medical Screening|March 17, 2007
Human papillomavirus testing by self-sampling: assessment of accuracy in an unsupervised clinical settingAnne Szarewski, Louise Cadman, Susan Mallett, et al.
British Journal of Cancer|March 1, 1991
c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodesW J Gullick, S B Love, C Wright, et al.
BMJ (Clinical Research Ed.)|November 13, 2008
Improving the reporting of pragmatic trials: an extension of the CONSORT statementMerrick Zwarenstein, Shaun Treweek, Joel J Gagnier, et al.
European Journal of Epidemiology|May 23, 2016
Statistical tests, P values, confidence intervals, and power: a guide to misinterpretationsSander Greenland, Stephen J Senn, Kenneth J Rothman, et al.
BMJ (Clinical Research Ed.)|June 10, 2017
Evolution of poor reporting and inadequate methods over time in 20 920 randomised controlled trials included in Cochrane reviews: research on research studyAgnes Dechartres, Ludovic Trinquart, Ignacio Atal, et al.
Heart (British Cardiac Society)|March 9, 2012
Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)markerKarel G M Moons, Andre Pascal Kengne, Mark Woodward, et al.
Annals of Internal Medicine|April 17, 2001
The revised CONSORT statement for reporting randomized trials: explanation and elaborationD G Altman, K F Schulz, D Moher, et al.
Pageof 97

Showing results (741-750 of 965) with videos related to

Sort By:
Pageof 97
BMJ (Clinical Research Ed.)|February 17, 2010
The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviewsJamie J Kirkham, Kerry M Dwan, Douglas G Altman, et al.
Health Technology Assessment (Winchester, England)|September 23, 2003
Evaluating non-randomised intervention studiesJ J Deeks, J Dinnes, R D'Amico, et al.
Systematic Reviews|April 16, 2014
Evaluation of the Cochrane Collaboration's tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementationJelena Savović, Laura Weeks, Jonathan A C Sterne, et al.
Journal of Medical Screening|March 17, 2007
Human papillomavirus testing by self-sampling: assessment of accuracy in an unsupervised clinical settingAnne Szarewski, Louise Cadman, Susan Mallett, et al.
British Journal of Cancer|March 1, 1991
c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodesW J Gullick, S B Love, C Wright, et al.
BMJ (Clinical Research Ed.)|November 13, 2008
Improving the reporting of pragmatic trials: an extension of the CONSORT statementMerrick Zwarenstein, Shaun Treweek, Joel J Gagnier, et al.
European Journal of Epidemiology|May 23, 2016
Statistical tests, P values, confidence intervals, and power: a guide to misinterpretationsSander Greenland, Stephen J Senn, Kenneth J Rothman, et al.
BMJ (Clinical Research Ed.)|June 10, 2017
Evolution of poor reporting and inadequate methods over time in 20 920 randomised controlled trials included in Cochrane reviews: research on research studyAgnes Dechartres, Ludovic Trinquart, Ignacio Atal, et al.
Heart (British Cardiac Society)|March 9, 2012
Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)markerKarel G M Moons, Andre Pascal Kengne, Mark Woodward, et al.
Annals of Internal Medicine|April 17, 2001
The revised CONSORT statement for reporting randomized trials: explanation and elaborationD G Altman, K F Schulz, D Moher, et al.
Pageof 97